4:48 PM
Sep 05, 2013
 |  BC Extra  |  Financial News

Bind sets IPO range

Bind Therapeutics Inc. (Cambridge, Mass.) amended its IPO and now plans to sell 4.7 million shares at $14-$16. At the $15 midpoint, the company would raise $70.1...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >